Skip to main content

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 68))

  • 69 Accesses

Abstract

The specificity of the immune response and its biologic compatibility with the normal tissues of the host are responsible for its great appeal to clinical scientists as a therapeutic intervention in patients with early or minimal residual cancer. Because carcinoma of the bronchus appears to be a carcinogen-induced cancer and because carcinogen-induced cancers are frequently, at least minimally immunogenic, this tumor seems a reasonably logical target for immunotherapeutic attack.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. Gehan, E.: A generalized two-sample Wilcoxon test for doubly censored data. Biometrika 52, 650–653 (1965).

    PubMed  CAS  Google Scholar 

  2. Hanna, M. G., Peters, L. C.: Efficacy of intralesional BCG therapy in guinea pigs with disseminated tumor. Cancer 36, 1298–1304 (1975).

    Article  PubMed  Google Scholar 

  3. Hollinshead, A. C., Stewart, T. H. M.: Lung tumour antigens. Procedures 3rd International Symposium Ca. Nieburg, H. E. (ed.). Basel: E. Karger (in press) (1978).

    Google Scholar 

  4. Martini, N., Beattie, E. J.: Results of surgical treatment in stage I lung cancer. J. Thorac. Cardiovasc. Surg. 74, 499–505 (1977).

    PubMed  CAS  Google Scholar 

  5. Matthews, M. J., Pickren, J., Kanhouwa, S.: Who has occult metastases? In: Perspectives in lung cancer. Williams, T. E. et al. (eds.), pp. 9-17. Frederick E. Jones Memorial Symposium in Thoracic Surgery. Columbus (Ohio), 1976. Basel: Karger 1977.

    Google Scholar 

  6. McKneally, M. F., Maver, C., Kausel, H. W.: Regional immunotherapy of lung cancer with intrapleural BCG. Lancet 1976 I, 377-379.

    Google Scholar 

  7. McKneally, M. F., Maver, C., Kausel, H. W., Alley, R. D.: Regional immunotherapy with intrapleural BCG for lung cancer. J. Thorac. Cardiovasc. Surg. 72, 333–338 (1976).

    PubMed  CAS  Google Scholar 

  8. Mountain, C. F.: Assessment of the role of surgery for control of lung cancer. Ann. Thorac. Surg. 24, 365–373 (1977).

    Article  PubMed  CAS  Google Scholar 

  9. Ruckdeschel, J. C., Codish, S. D., Stranahan, A., McKneally, M. F.: Postoperative empyema improves survival in lung cancer: Documentation and analysis of a natural experiment. N. Engl. J. Med. 287, 1013–1017 (1972).

    Article  PubMed  CAS  Google Scholar 

  10. Takita, H.: Effect of postoperative empyema on survival of patients with bronchogenic carcinoma. J. Thorac. Cardiovasc. Surg. 59, 642–644 (1970).

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

McKneally, M.F., Maver, C., Kellar, S., Lininger, L. (1979). Patterns of Recurrence After Regional BCG Immunotherapy of Bronchial Cancer. In: Bonadonna, G., Mathé, G., Salmon, S.E. (eds) Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II. Recent Results in Cancer Research, vol 68. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81332-0_44

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81332-0_44

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81334-4

  • Online ISBN: 978-3-642-81332-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics